ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Water → 4-(5-{4-[2-(4-Methoxy-phenyl)-ethyl]-piperazin-1-yl}-[1,2,4]thiadiazol-3-yl)-benzonitrile

HRID 570575
印刷

反応式

HRID 570575 の反応式
Cl[C:2]1[N:6]=[C:5]([N:7]2[CH2:12][CH2:11][N:10]([CH2:13][CH2:14][C:15]3[CH:20]=[CH:19][C:18]([O:21][CH3:22])=[CH:17][CH:16]=3)[CH2:9][CH2:8]2)[S:4][N:3]=1.[C:23]([C:25]1[CH:30]=[CH:29][C:28](B(O)O)=[CH:27][CH:26]=1)#[N:24].C([O-])([O-])=O.[Na+].[Na+].O>COCCOC.[Pd].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.CCOC(C)=O>[CH3:22][O:21][C:18]1[CH:19]=[CH:20][C:15]([CH2:14][CH2:13][N:10]2[CH2:11][CH2:12][N:7]([C:5]3[S:4][N:3]=[C:2]([C:28]4[CH:29]=[CH:30][C:25]([C:23]#[N:24])=[CH:26][CH:27]=4)[N:6]=3)[CH2:8][CH2:9]2)=[CH:16][CH:17]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 962WaterHCID 10340Sodium CarbonateHCID 27343264-Cyanophenylboronic acidHCID 711872633-Chloro-5-(4-(4-methoxyphenethyl)piperazin-1-yl)-1,2,4-thiadiazole

生成物 1

HCID 711862924-(5-{4-[2-(4-Methoxy-phenyl)-ethyl]-piperazin-1-yl}-[1,2,4]thiadiazol-3-yl)-benzonitrile

試薬・触媒・溶媒 3

HCID 11979704
Tetrakis(triphenylphosphine)palladium
触媒
HCID 80711,2-Dimethoxyethane溶媒
HCID 8857Ethyl Acetate溶媒

反応条件

温度
110 °C

実験手順

A 5 ml micro wave vial was charged with 3-chloro-5-(4-(4-methoxyphenethyl)piperazin-1-yl)-1,2,4-thiadiazole (50 mg, 148 μmol) in 3 mL DME. 4-Cyanophenylboronic acid (26.0 mg, 177 μmol), Na2CO3 (18.8 mg, 177 μmol), tetrakis(triphenylphosphine) palladium (0) (3.41 mg, 2.95 μmol) and water (1.5 mL) was added. The vial was capped and the mixture was heated in oil bath at 110° C. over night. 2 mL EtOAc were added and the aqueous part was separated. The organic layer was dried over Na2SO4, filtered off and concentrated in vacuo. The crude product was dissolved in MeCN (3 mL)/DIPEA (100 μL) and purified by preparative HPLC on reversed phase eluting with a gradient formed from MeCN, water and NEt3 to yield, after evaporation of the product containing fractions, 13.6 mg (23%) of the title compound as white solid. MS (m/e): 406.3 (MH+).

後処理

  1. customThe vial was capped
  2. customthe aqueous part was separated
  3. dry with materialThe organic layer was dried over Na2SO4
  4. filtrationfiltered off
  5. concentrationconcentrated in vacuo
  6. dissolutionThe crude product was dissolved in MeCN (3 mL)/DIPEA (100 μL)
  7. custompurified by preparative HPLC on reversed phase
  8. washeluting with a gradient
  9. customformed from MeCN, water and NEt3
  10. customto yield
  11. customafter evaporation of the product
  12. additioncontaining fractions, 13.6 mg (23%) of the title compound as white solid

出典と根拠

ORDレコード
ord-afadf81c9ca348a28614ed5d8b059866
出典データセット
uspto-grants-2015_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09023852B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート